Group 1: Investor Relations Activity - The company held an annual performance briefing on April 17, 2025, via the "Investor Relations Interactive Platform" [3] - Key personnel present included the Chairman, General Manager, and other executives [3] Group 2: Performance Overview - The company faced a revenue decline in 2024 primarily due to underperformance in the defense market, which significantly impacted revenue and profit [6] - R&D investment was high, accounting for 11.33% of revenue, due to an increase in new projects [6] - The commercial aerospace sector did not meet expected launch plans, affecting revenue growth [6] - Despite significant revenue growth in the civil communication sector, its low gross margin limited profit contributions [6] Group 3: Financial Health - As of December 31, 2024, net accounts receivable amounted to 565.88 million yuan, a 28.89% increase from the beginning of the period [7] - Accounts receivable represented 39.66% of total assets and 55.94% of current assets, with 82.08% of accounts receivable aged within one year [7] - The company plans to implement strict sales management and credit control measures to mitigate operational risks [7] Group 4: Cost Control and Competitive Strategy - The company is implementing efficiency projects to achieve cost reduction, including material optimization and automation [9] - It aims to enhance R&D investment focusing on low-cost, miniaturized, high-frequency, and integrated technologies [10] - A specialized R&D team will be established to ensure forward-looking research in core technology areas [10] Group 5: Market Outlook - The commercial satellite sector is expected to maintain stable growth in 2025, with ongoing collaboration with core customers [11] - The company offers low-cost, high-reliability interconnection solutions for the aerospace sector, supporting multiple space missions [12] Group 6: Corporate Governance - The company has established a value management system in response to regulatory requirements and aims for sustainable growth [13] - It emphasizes high-quality information disclosure and investor engagement to enhance understanding of its strategic goals [13] Group 7: New Product Development - The 400G high-speed copper cable prototype line was completed by the end of 2024, with ongoing product expansion and customer validation [14] - The expected contribution of this product to the company's performance in 2025 is anticipated to be minimal [14]

证券代码：300529 证券简称：健帆生物 债券代码：123117 债券简称：健帆转债 健帆生物科技集团股份有限公司 投资者关系活动记录表 编号：2025-001 | | □ □ 分析师会议 | 特定对象调研 | | --- | --- | --- | | 投资者关系 活动类别 | □ 业绩说明会 | □ 媒体采访 | | | □ 路演活动 | □ 新闻发布会 | | | □ √ 其他（线上会议） | 现场参观 | | 参与人员 | 华泰证券、西南证券、东北证券、国盛证券、国金证券、东吴证券、中信建投 证券、中信证券、国信证券、中邮证券、西部证券、南方基金、大成基金、博 | | | | 证券、华福证券、申万宏源证券、兴业证券、国联民生证券、国信证券、中泰 | | | | 时基金、上海人寿、招商基金、新华基金、中航基金、友邦人寿、红杉中国、 | | | | 华夏基金、广发基金、中银基金、景顺长城基金、IDG 资本、工银瑞信等七十 | | | | | 余位投资者 | | 时间 | 日 2025 | 年 月 4 16 | | 地点 | | 线上沟通 | | 上市公司接 | 董事长、总经理：董凡 | | | | 董事 ...

证券代码：002428 证券简称：云南锗业 云南临沧鑫圆锗业股份有限公司 投资者关系活动记录表 编号：2025-004 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 ☑业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 □其他 （请文字说明其他活动内容） | | 活动参与人员 | 参与云南锗业 2024 年度网上业绩说明会的投资者。 | | 时间 | 2025 年 4 月 18 日 | | 地点 | 全景网"投资者关系互动平台"（https://ir.p5w.net） | | 上市公司接待人 | 董事长、总经理：包文东； | | 员姓名 | 董事、副总经理、财务总监：杨元杰； | | | 独立董事：方自维、龙超、黄松； | | | 副总经理、董事会秘书：金洪国。 | | | 公司于 2025 年 4 月 18 日（周五）15：00-17：00 在全景网举办 2024 | | | 年度网上业绩说明会，本次年度业绩说明会采用网络远程的方式举行，问答 环节主要内容如下： | | | 1、关于现金流与净利润增长不匹配的问题，年报显 ...

证券代码：300548 证券简称：博创科技 博创科技股份有限公司 博创科技 2024 年度业绩说明会 投资者活动记录表 编号：2025-001 4.请问贵公司未来盈利增长的主要驱动因素有哪些？ 答：感谢您对公司的关注！公司未来盈利增长的主要驱动因素在于稳定的 国际局势、积极的财政政策、AI 需求的持续增长以及公司在高速互联上的 技术突破和领先等多个方面。 5. 公司能否尽快提前预披露一季报，坚定小股东信心？ 答：您好！公司《2025 年第一季度报告》将于 4 月底披露，敬请关注。 6.贵司美国业务占比多少？关税大战对贵司的影响多大？贵司在英国和印 尼有设厂，海外产能是否足够降低关税带来的影响？ | | □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 | | --- | --- | | 投资者关系活动 | | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 □电话会议 | | | □其他： （请文字说明其他活动内容） | | 参与单位名称 | 博创科技2024年度业绩说明会采用网络远程方式进行，面向全体投资者 | | 及人员姓名 | | | 时间 | 年 月 日 2025 4 18 15 ...

证券代码：301167 证券简称：建研设计 安徽省建筑设计研究总院股份有限公司 投资者关系活动记录表 编号：2025-003 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | 投资者关系活动 | ☐新闻发布会 ☐路演活动 | | 类别 | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及 | 线上参与公司2024年度业绩说明会的全体投资者 | | 人员姓名 | | | 时间 | 2025年04月18日 15:00-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/）网络互动 | | | 董事长 韦法华先生 | | | 总经理 汤健先生 | | 上市公司接待人 | 副总经理、董事会秘书 王红兵先生 | | 员姓名 | 财务总监 刘定萍女士 | | | 独立董事 周萍华女士 | | | 保荐代表人 王兴禹先生 1.近期二级市场股价大幅下跌，为落实中国证监会和国务院 | | | 国资委关于上市公司市值管理工作的相关部署，安徽省国资委、 安徽证监局联合在全国率先印发《关于加强省属企业控 ...

证券代码：300142 证券简称：沃森生物 云南沃森生物技术股份有限公司投资者关系活动记录表 编号：2025-001 投资者关系活动 类别 □ 特定对象调研 □ 分析师会议 □ 媒体采访 √ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他（ ） 活动参与单位名 称及人员姓名 线上参与公司 2024 年度业绩网上说明会的全体投资者 时间 2025 年 4 月 18 日 15:00-17:00 地点 价值在线（https://www.ir-online.cn/） 形式 网络平台线上交流 上市公司接待人 员姓名 董事长 李云春 董事、总裁 姚伟 独立董事 朱锦余 副总裁 吴云燕 财务总监 吴昌雄 董事会秘书 刘宇然 投资者关系活动 交流内容及具体 问答记录 1. 13 价肺炎球菌多糖结合疫苗在国内市场份额领先，是否有计划 进一步扩大市场份额？ 答：尊敬的投资者，您好！公司持续深耕国内市场，并不断拓展国 际市场。国内市场方面，公司采取科普宣传、学术交流、品牌营销等多 种方式拓展市场，深入挖掘以 13 价肺炎结合疫苗为代表的公司自主生 产疫苗产品的市场潜力，持续提升公司疫苗产品渗透率。国际市场方 面， ...

证券代码：301367 证券简称：怡和嘉业 北京怡和嘉业医疗科技股份有限公司 投资者关系活动记录表 编号：2025—002 | □ | 特定对象调研 □ 分析师会议 | | --- | --- | | 投资者关系活动 | □ 媒体采访 √ 业绩说明会（电话形式） | | 类别 | □ 新闻发布会 □ 路演活动 | | □ | 现场参观 | | □ | 其他 | | 参与单位名称 | 详见附件清单 | | 时间 | 年 月 日 2025 4 18 | | 地点 | 电话会议 | | 上市公司接待人 | 副总经理兼董事会秘书：杜祎程 | | 员姓名 | 副总经理兼财务总监：暴楠 | | | 证券事务代表：刘士岩 | | | 一、公司简要介绍 | | | 公司 年成立，2003 年第一台多导睡眠监测仪上市，2007 2001 | | | 年第一台 CPAP 睡眠呼吸机上市，2008 年通过 CE 认证，2012 年 | | | 通过美国 认证，2016 年 新品牌成立，同年呼吸数据管 FDA BMC | | | 理云上线，2022 年 11 月 1 日公司在深交所创业板上市成功。 | | 投资者关系活动 | 公司专 ...

Group 1: Investor Relations Activity - The investor relations activity was an earnings briefing held on April 17, 2025, from 15:00 to 17:00 via the interactive platform [3] - Participants included the Chairman, General Manager, and other board members [3][4] Group 2: Company Performance - In 2024, the company achieved a revenue of CNY 232 million, a year-on-year increase of 10.09% [12] - Net profit for the same period was CNY 21.06 million, a decline of 40.81% [12] - Gross margin stood at 36.31%, an increase of 0.97 percentage points compared to the previous year [12] Group 3: Market Insights - The company has received orders in various sectors including humanoid robots, industrial robots, and medical devices [5][14] - The demand for harmonic reducers is driven by the global trend of automation and the rise of robotics, particularly in high-end equipment [6] - The company aims to align its harmonic reducer products with international standards, utilizing Japanese processing technology [8] Group 4: Future Growth and Strategy - The company is focusing on expanding its market share in the semiconductor, industrial automation, and automotive sectors, which have significant growth potential [10] - Plans for future production of harmonic reducers are in place, with readiness for mass production based on market demand [14] - The establishment of overseas subsidiaries is part of the strategy to enhance market presence and brand influence [11][16] Group 5: Financial Strategies - In July 2024, the company repurchased 3 million shares for a total of CNY 34.08 million, intended for employee stock ownership plans [18] - The company is considering various strategic opportunities for mergers and acquisitions to support its growth [19] Group 6: Corporate Governance - The company has implemented a market value management system to enhance operational management and internal value [20]

Group 1: Company Overview and Products - The company focuses on the development, production, and sales of sonar equipment in the national special electronic information industry [1][2] - Key products include signal processing platforms, sonar systems, underwater big data, simulation training systems, unmanned detection systems, and data centers, primarily serving national special departments [2] Group 2: Financial Performance in 2024 - The company's operating revenue for 2024 was 239.71 million yuan, a 45.65% increase from the adjusted revenue of 164.58 million yuan in the previous year [3] - Revenue breakdown: - Signal processing platforms: 158.91 million yuan - Sonar systems: 59.46 million yuan - Underwater big data and simulation systems: 12.06 million yuan - Unmanned detection systems: 7.17 million yuan [3] - The net profit attributable to shareholders was -26.14 million yuan, indicating a loss [3] - The net cash flow from operating activities was 24.95 million yuan, a 135.42% increase from -70.45 million yuan in the previous year [3] Group 3: Product Development and Innovations - The company has developed a new generation heterogeneous high-performance signal processing platform based on GPU chips, with expected mass orders in 2025 [7] - The HX-A200 domestically produced core processing chip has been developed and tested, aimed at sonar equipment data computation needs [7] - The unmanned detection system generated revenue for the first time in 2024, with a batch delivery of a certain unmanned autonomous release and recovery system [7] Group 4: Cash Flow and Accounts Receivable Management - The company improved its accounts receivable management, with cash received from sales amounting to 344.51 million yuan, a 91.88% increase from 179.54 million yuan in the previous year [10] - Plans to enhance collection efforts on long-aged accounts to reduce bad debt risk and improve cash flow efficiency in 2025 [10] Group 5: Future Projects and Market Expansion - The company completed the system integration of a certain data computing center project in 2024, with the second phase successfully winning a bid in 2025 [11] - Future business will focus on multi-level data computing center construction for training bases, research institutes, and support organizations [11]

2. 公司在零食专营渠道的进展情况？ 证券代码：300997 证券简称：欢乐家 欢乐家食品集团股份有限公司投资者关系活动记录表 编号：2025-007 | | √特定对象调研 □分析师会议 | | --- | --- | | | □媒体采访 □业绩说明会 | | 投资者关系活动类别 | □新闻发布会 □路演活动 | | | √现场参观 | | | □其他 | | 参与单位名称及人员 | 具体参与单位名称见附件 | | 时间 | 2025年4月18日 | | 地点 | 湛江市欢乐家大厦会议室 | | 上市公司接待人员姓名 | 副董事长兼总裁 李子豪 | | | 董事兼副总裁 程松 | | | 副总裁 杨榕华 | | | 副总裁兼财务总监 翁苏闽 | | | 副总裁兼董事会秘书 范崇澜 主要内容如下： | | 1. | 公司对于水果罐头类产品、椰子汁类产品和椰子水产 品的发展规划和产品定位？ | | | 公司坚持以水果罐头和椰子汁为双驱动的发展战 | | 投资者关系活动主要内 | 略，以椰子汁和水果罐头产品为核心基础，围绕口感、健 | | 容介绍 | 康、功能等方面，根据消费者的饮食习惯进行产品的开发 | | | ...